Palvella Therapeutics (PVLA) Asset Utilization Ratio (2016 - 2024)
Historic Asset Utilization Ratio for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to 0.06.
- Palvella Therapeutics' Asset Utilization Ratio fell 9081.66% to 0.06 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.06, marking a year-over-year decrease of 9081.66%. This contributed to the annual value of 0.83 for FY2023, which is 29948.55% up from last year.
- As of Q3 2024, Palvella Therapeutics' Asset Utilization Ratio stood at 0.06, which was down 9081.66% from 0.77 recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Asset Utilization Ratio ranged from a high of 2.21 in Q1 2024 and a low of 0.06 during Q3 2024
- For the 5-year period, Palvella Therapeutics' Asset Utilization Ratio averaged around 0.46, with its median value being 0.27 (2022).
- Examining YoY changes over the last 5 years, Palvella Therapeutics' Asset Utilization Ratio showed a top increase of 106121.02% in 2024 and a maximum decrease of 9081.66% in 2024.
- Over the past 5 years, Palvella Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.27 in 2020, then tumbled by 31.81% to 0.18 in 2021, then soared by 47.98% to 0.27 in 2022, then skyrocketed by 378.35% to 1.28 in 2023, then crashed by 95.37% to 0.06 in 2024.
- Its last three reported values are 0.06 in Q3 2024, 0.77 for Q2 2024, and 2.21 during Q1 2024.